Client applications and Server Side docker for management of RNASeq and/or VariantSeq workflows and pipelines of the GPRO Suite

Autor: Hafez, Ahmed, Soriano, Beatriz, Elsayed, Aya A., Futami, Ricardo, Ceprian, Raquel, Ramos-Ruiz, Ricardo, Martinez, Genis, Roig, Francisco J., Torres-Font, Miguel A., Naya-Català, Fernando, Calduch-Giner, Josep Alvar, Trilla-Fuertes, Lucia, Gamez-Pozo, Angelo, Arnau, Vicente, Sempere, Jose M., Perez-Sánchez, Jaume, Gabaldón, Toni, Llorens, Carlos

The GPRO suite is an in-progress bioinformatic project for -omic data analyses. As part of the continued growth of this project, we introduce a client side & server side solution for comparative transcriptomics and analysis of variants. The client si

Externí odkaz: http://arxiv.org/abs/2202.07473

An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer

Autor: Cejas Paloma, Feliu Jaime, Redondo Andrés, Zamora Pilar, San José Belén, López Rocío, Madero Rosario, Hardisson David, Pinto Álvaro, Gámez-Pozo Angelo, Sánchez-Navarro Iker, González Barón Manuel, Ángel Fresno Vara Juan, Espinosa Enrique

Publikováno v: BMC Cancer, Vol 10, Iss 1, p 336 (2010)

Abstract Background Gene expression profiling may improve prognostic accuracy in patients with early breast cancer. Our objective was to demonstrate that it is possible to develop a simple molecular signature to predict distant relapse. Methods We in

Externí odkaz: https://doaj.org/article/541cd6cbc5254a9592c29a9eadb3dc83

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.

Autor: Trilla-Fuertes, Lucía¹ (AUTHOR) lucia.lt30@gmail.com, Gámez-Pozo, Angelo^1,2 (AUTHOR) angelogamez@gmail.com, Prado-Vázquez, Guillermo^1,2 (AUTHOR) 14gprado@gmail.com, López-Vacas, Rocío¹ (AUTHOR) rlvacas@gmail.com, Soriano, Virtudes^3,4 (AUTHOR) fernando.garicanogoldaraz@osakidetza.eus, Garicano, Fernando^4,5 (AUTHOR) mjlecumberri@yahoo.es, Lecumberri, M. José^4,6 (AUTHOR) mararch3@hotmail.com, Rodríguez de la Borbolla, María^4,7 (AUTHOR) mmajem@santpau.cat, Majem, Margarita^4,8 (AUTHOR) eliperu@gmail.com, Pérez-Ruiz, Elisabeth^4,9 (AUTHOR) mgocao@gmail.com, González-Cao, María^4,10 (AUTHOR) juanaoramas@gmail.com, Oramas, Juana^4,11 (AUTHOR) magdaleno.cremades@gmail.com, Magdaleno, Alejandra^4,12 (AUTHOR) jfrar@seom.org, Fra, Joaquín^4,13 (AUTHOR) monicacorral72@hotmail.com, Martín-Carnicero, Alfonso^4,14 (AUTHOR) tjpuertolas@gmail.com, Corral, Mónica^4,15 (AUTHOR), Puértolas, Teresa^4,16 (AUTHOR), Ramos-Ruiz, Ricardo¹⁷ (AUTHOR) ricardo.ramos@fpcm.es, Dittmann, Antje¹⁸ (AUTHOR) antje.dittmann@fgcz.ethz.ch, Nanni, Paolo¹⁸ (AUTHOR) paolo.nanni@fgcz.uzh.ch

Publikováno v: Cancers. Sep2023, Vol. 15 Issue 17, p4407. 13p.

Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab

Autor: Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Joan Maurel, Rocio Garcia-Carbonero, Jaume Capdevila, Laura G-Pastrián, Marta Mendiola, Cristina Peña, Rocío López-Vacas, Miriam Cuatrecasas, Pilar García-Alfonso, Ricardo Ramos-Ruiz, Carlos Llorens, Ismael Ghanem, Carles Conill, Victoria Heredia-Soto, Ángel Campos-Barros, Juan Ángel Fresno Vara, Jaime Feliu

Publikováno v: Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)

Abstract Squamous cell carcinoma is the most frequent histologic type of anal carcinoma. The standard of care since the 1970s has been a combination of 5-fluorouracil, mitomycin C, and radiotherapy. This treatment is very effective in T1/T2 tumors (a

Externí odkaz: https://doaj.org/article/d4fe26f9fdff4908953ce34c605cf410

Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer

Autor: Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Elena López-Camacho, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Rocío López-Vacas, Jorge M. Arevalillo, Mariana Díaz-Almirón, Hilario Navarro, Paloma Maín, Enrique Espinosa, Pilar Zamora, Juan Ángel Fresno Vara

Publikováno v: BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)

Abstract Background Metabolomics has a great potential in the development of new biomarkers in cancer and it has experiment recent technical advances. Methods In this study, metabolomics and gene expression data from 67 localized (stage I to IIIB) br

Externí odkaz: https://doaj.org/article/b0992cc46a1c43dca0e68fab2cd0fd3e